The patient's prothrombin time is 15 seconds; what dose of vitamin K should be administered?

Vitamin K Dosing for PT 15 Seconds

For a prothrombin time of 15 seconds without active bleeding or urgent procedures, vitamin K is generally not indicated unless the INR is significantly elevated (≥1.4) or the patient requires urgent reversal.

Clinical Context Assessment

A PT of 15 seconds alone is insufficient to determine vitamin K dosing—you must know the INR value and clinical context 1, 2:

• Normal PT range: typically 11-13.5 seconds (varies by laboratory)
• PT 15 seconds may correspond to an INR of approximately 1.3-1.5, which is minimally elevated
• Clinical bleeding status and urgency of procedures dictate management intensity

Vitamin K Dosing Algorithm

For Warfarin-Associated Coagulopathy WITHOUT Active Bleeding:

If INR 1.3-1.9 (likely with PT ~15 sec):

• No vitamin K needed in most cases—simply hold or reduce warfarin dose 3
• Consider 1-2.5 mg oral vitamin K if rapid correction desired (corrects INR within 24-48 hours) 4

If INR ≥1.4 with intracranial hemorrhage:

• 10 mg IV vitamin K immediately, given slowly (≤1 mg/min) 1, 2
• Repeat 10 mg IV if INR remains ≥1.4 at 24-48 hours 1
• Must be combined with prothrombin complex concentrate (PCC) for urgent reversal 1

If INR 5.0-9.0 without bleeding:

• 1-2.5 mg oral vitamin K (preferred route to avoid anaphylaxis risk) 4
• Corrects to INR 2.0-5.0 within 24-48 hours 4

If INR >10.0 without bleeding:

• 5 mg oral vitamin K 4

For Warfarin-Associated Coagulopathy WITH Active Bleeding:

Non-life-threatening bleeding:

• 5 mg IV vitamin K as initial dose 5
• Recheck INR in 4-5 hours—median decrease from 5.8 to 2.5 achieved 5
• 59% of patients achieve INR ≤2.5 with vitamin K alone, avoiding need for PCC 5

Life-threatening bleeding or urgent surgery:

• 10 mg IV vitamin K plus 4-factor PCC (weight and INR-based dosing) 1, 2
• Vitamin K ensures durable reversal beyond PCC's immediate effect 1

Route of Administration Hierarchy

1. Oral route preferred for non-urgent situations (avoids anaphylaxis risk) 4
2. Subcutaneous route effective alternative (4.9 mg average dose corrects excessive INR) 6
3. IV route reserved for urgent/emergent situations, given slowly ≤1 mg/min 1, 2

Critical Dosing Considerations

Avoid overcorrection:

• Doses >2.5 mg increase risk of INR <2.0, causing warfarin resistance 7
• In one study, 0.5 mg IV achieved optimal response (INR 2-4) in 67% vs. only 33% with 1-2 mg 7

Severely elevated INR (>9.5 with aPTT ratio >2):

• May require repeat dosing regardless of initial vitamin K dose 7
• 5 of 6 such patients failed to achieve INR ≤4.0 on day 1 7

Time to effect:

• IV vitamin K begins working within 4-5 hours 5
• Full effect takes 12-36 hours 3
• Oral vitamin K requires 24-48 hours for full correction 4

Common Pitfalls

• Do not give vitamin K for minimally elevated PT/INR (1.3-1.9) without bleeding—this represents mild coagulopathy that often self-corrects 3
• Never use IV route casually—anaphylactoid reactions can occur; reserve for true emergencies 2, 4
• Do not use vitamin K alone for life-threatening bleeding—must combine with PCC or fresh frozen plasma for immediate factor replacement 1, 2
• Remember vitamin K is less effective for acenocoumarol or phenprocoumon compared to warfarin 4